Order Article Reprints

Bianchi FP, Stefanizzi P, Germinario CA, Migliore G, Vimercati L, Martinelli A, Lobifaro A, Diella G, Larocca AMV, Control Room Working Group, et al. Medium-to-Long-Term Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine: A Retrospective Cohort Study. Vaccines. 2022; 10(3):417. https://doi.org/10.3390/vaccines10030417

Bianchi, Francesco Paolo, Pasquale Stefanizzi, Cinzia Annatea Germinario, Giovanni Migliore, Luigi Vimercati, Andrea Martinelli, Annamaria Lobifaro, Giusy Diella, Angela Maria Vittoria Larocca, Control Room Working Group, and et al. 2022. "Medium-to-Long-Term Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine: A Retrospective Cohort Study" Vaccines 10, no. 3: 417. https://doi.org/10.3390/vaccines10030417

Bianchi, F. P., Stefanizzi, P., Germinario, C. A., Migliore, G., Vimercati, L., Martinelli, A., Lobifaro, A., Diella, G., Larocca, A. M. V., Control Room Working Group, & Tafuri, S. (2022). Medium-to-Long-Term Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine: A Retrospective Cohort Study. Vaccines, 10(3), 417. https://doi.org/10.3390/vaccines10030417